ch.oddb.org
 
Analysen | Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Tresiba®:Novo Nordisk Pharma AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
A10AE06 - Insulin DegludecATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A10 - Drugs Used in Diabetes
 
A10A - Insulins and Analogues

This group comprises both human - and animal insulins.
Insulin preparations are classified at 4 different 4th levels, according to onset and duration of action. Each 4th level is differentiated in 5th levels according to origin of insulin.
Products consisting of, e.g. beef and pork insulin, are classified as combinations (30-levels) at each 4th level according to onset and duration of action.

The DDD for insulins is 40 units.

A10AE - Insulins and Analogues for Injection, Long-Acting
 
A10AE06 - Insulin Degludec
StärkeAdm.RouteNote
40 UP 
2018 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home